Category: 11. Valvular Heart Disease: Therapy Background: Women have higher mortality than men after mitral regurgitation (MR) surgery. To ascertain gender differences with percutaneous mitral valve repair, we compared baseline characteristics, safety and effectiveness at 1 y in 128 men and 83 women with MR 3+/4+ enrolled in the EVEREST II High Risk Cohort (EIIHRC).
Conclusion:
In the EIIHRC, women treated with MitraClip had similar MR improvement without higher MAE. Although smaller baseline LV volumes suggested an earlier stage of disease, indexed LV volumes were similar. The greater improvement in LVEF suggests that lower LV volumes should be thresholds for treatment in women. 
